The Hybrid Capture II human papillomavirus (HPV) DNA test is approved by the FDA
In 1999, The Hybrid Capture II human papillomavirus (HPV) DNA test was approved by the FDA as a test that can be used in conjunction with the Pap smear in screening for cervical cancer.
Tags:
Source: U.S. Food and Drug Administration
Credit:
